What is the recommended evaluation and management of costochondritis in a patient with systemic sclerosis (scleroderma)?

Costochondritis in Systemic Sclerosis

Direct Recommendation

Treat costochondritis in scleroderma patients with acetaminophen or NSAIDs (where safe and appropriate), advise activity modification to avoid chest muscle overuse, and provide reassurance that this is typically a self-limited benign condition—but first rule out cardiac causes given the high cardiovascular risk in this population. 1

Initial Evaluation: Cardiac Exclusion is Critical

The evaluation approach must be more aggressive in scleroderma patients than in the general population:

• Any scleroderma patient over 35 years or with cardiovascular risk factors presenting with chest pain requires electrocardiogram and likely chest radiograph before attributing symptoms to costochondritis. 1
• Coronary artery disease is present in 3-6% of patients with chest pain and chest wall tenderness to palpation, making cardiac exclusion mandatory. 1
• Scleroderma patients have significant pulmonary vascular disease risk (present in ~20% of SSc patients) and interstitial lung disease (40-75% of patients), which can present with chest discomfort. 2, 3
• High-resolution CT scanning may be warranted if there is any concern for pulmonary involvement, as it is a key method for evaluating chest involvement in SSc. 3

Diagnostic Confirmation of Costochondritis

Once cardiac and pulmonary causes are excluded:

• Diagnosis requires reproducible chest pain by palpation over the costal cartilages or chondrosternal joints. 1
• Palpation of affected chondrosternal joints elicits focal tenderness that reproduces the patient's pain. 1
• In younger patients without cardiac risk factors, history and physical examination documenting reproducible palpation tenderness are usually sufficient. 1

Treatment Algorithm

First-Line Management

• Acetaminophen or anti-inflammatory medications (NSAIDs) where safe and appropriate. 1
• Advise patients to avoid activities producing chest muscle overuse. 1
• Provide reassurance about the benign, self-limiting nature of the condition. 1

Important Caveat: NSAID Use in Scleroderma

• Exercise caution with NSAIDs in scleroderma patients due to potential renal complications, as scleroderma renal crisis is a serious complication requiring careful monitoring of renal function. 4
• Patients on corticosteroids (which may be used for other SSc manifestations) have higher risk of scleroderma renal crisis and require careful blood pressure and renal function monitoring. 4

Refractory Cases (Atypical Costochondritis)

If symptoms persist beyond several weeks:

• Consider physical therapy with manipulative techniques, including rib manipulation and instrument-assisted soft tissue mobilization (IASTM). 5
• Osteopathic manipulation techniques can address rib dysfunction and myofascial pain generators. 5
• Atypical costochondritis (non-self-resolving) is associated with high medical expenses and psychological burden, warranting more aggressive intervention. 5

Common Pitfalls to Avoid

• Never assume chest pain is costochondritis without cardiac workup in scleroderma patients, given their multisystem vascular disease. 2, 6
• Do not overlook that nearly 90% of SSc patients have gastrointestinal involvement, which can cause chest discomfort mimicking costochondritis. 2
• Avoid high-dose corticosteroids if considering them for any reason, as they increase scleroderma renal crisis risk. 4
• Remember that pulmonary arterial hypertension can be an isolated manifestation of SSc and may present with chest discomfort. 2, 3